The largest community of pharma leaders

Dyne Therapeutics Appoints Catherine Stehman-Breen to its Board of Directors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dyne Therapeutics today announced the appointment of Catherine Stehman-Breen, M.D., to its Board of Directors.

Recent Articles

2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.